Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.5B | 14.1B | 13.5B | 12.8B |
| Cost of revenue | 10.7B | 11.1B | 10.6B | 9.8B |
| Gross profit | 2.8B | 3.0B | 2.9B | 3.0B |
| Operating expense | ||||
| Research & development | 397M | 392M | 413M | 436M |
| Selling general and admin | 1.5B | 1.4B | 1.4B | 1.5B |
| Other operating expenses | — | — | — | — |
| Operating income | 921M | 1.1B | 1.0B | 1.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 141M | 147M | 149M | 162M |
| Other income expense | -76M | -115M | -32M | -86M |
| Pretax income | 704M | 862M | 827M | 797M |
| Tax provision | 139M | -44M | 187M | 190M |
| Net income | 565M | 906M | 640M | 607M |
| Basic EPS | 0.6 | 0.9 | 0.7 | 0.6 |
| Diluted EPS | 0.6 | 0.9 | 0.7 | 0.6 |
| Basic average shares | 48.8M | 49.3M | 50.4M | 50.6M |
| Diluted average shares | 49.2M | 50.0M | 50.9M | 50.9M |
| EBITDA | 1.1B | 1.4B | 1.3B | 1.3B |
| Net income from continuing op. | 565M | 906M | 640M | 607M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |